Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 211

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Equol: Pharmacokinetics and Biological Actions ,

Open access
Setchell, Kenneth D.R., Clerici, Carlo · 2010 · The Journal of Nutrition

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3945/jn.109.119784

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 84

  1. Jensen, 1962, On the mechanism of estrogen action, Perspect Biol Med, 6, 47, 10.1353/pbm.1963.0005 · DOI · Paper page
  2. Kuiper, 1996, Cloning of a novel receptor expressed in rat prostate and ovary, Proc Natl Acad Sci USA, 93, 5925, 10.1073/pnas.93.12.5925 · DOI · Paper page
  3. Morito, 2001, Interaction of phytoestrogens with estrogen receptors α and β, Biol Pharm Bull, 24, 351, 10.1248/bpb.24.351 · DOI · Paper page
  4. Muthyala, 2004, Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta, Bioorg Med Chem, 12, 1559, 10.1016/j.bmc.2003.11.035 · DOI · Paper page
  5. Lund, 2004, Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback, Biol Reprod, 70, 1188, 10.1095/biolreprod.103.023713 · DOI · Paper page
  6. Setchell, 2009, The pharmacokinetic behavior of the soy isoflavone metabolite S- (-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers, Am J Clin Nutr, 90, 1029, 10.3945/ajcn.2009.27981 · DOI
  7. Setchell, 2009, The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women, J Nutr, 139, 2037, 10.3945/jn.109.110874 · DOI
  8. Axelson, 1980, Conjugation of lignans in human urine, FEBS Lett, 122, 49, 10.1016/0014-5793(80)80399-1 · DOI
  9. Axelson, 1982, The identification of the weak oestrogen equol [7-hydroxy-3-(4’-hydroxyphenyl)chroman] in human urine, Biochem J, 201, 353, 10.1042/bj2010353 · DOI · Paper page
  10. Axelson, 1984, Soya: a dietary source of the non-steroidal oestrogen equol in man and animals, J Endocrinol, 102, 49, 10.1677/joe.0.1020049 · DOI · Paper page
  11. Sfakianos, 1997, Intestinal uptake and biliary excretion of the isoflavone genistein in rats, J Nutr, 127, 1260, 10.1093/jn/127.7.1260 · DOI · Paper page
  12. Doerge, 2000, Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry, Drug Metab Dispos, 28, 298, 10.1016/S0090-9556(24)15365-2 · DOI · Paper page
  13. Shelnutt, 2002, Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage, Am J Clin Nutr, 76, 588, 10.1093/ajcn/76.3.588 · DOI · Paper page
  14. Shelnutt, 2000, Urinary pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein, Cancer Epidemiol Biomarkers Prev, 9, 413
  15. Ronis, 2006, Sulfation of the isoflavones genistein and daidzein in human and rat liver and gastrointestinal tract, J Med Food, 9, 348, 10.1089/jmf.2006.9.348 · DOI
  16. Strassburg, 1998, Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8, J Biol Chem, 273, 8719, 10.1074/jbc.273.15.8719 · DOI · Paper page
  17. Setchell, 2001, Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements, J Nutr, 131, S1362, 10.1093/jn/131.4.1362S · DOI · Paper page
  18. Setchell, 2003, Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women, Am J Clin Nutr, 77, 411, 10.1093/ajcn/77.2.411 · DOI · Paper page
  19. Nagel, 1998, The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity, Proc Soc Exp Biol Med, 217, 300, 10.3181/00379727-217-44236 · DOI · Paper page
  20. Garreau, 1991, Phytoestrogens: new ligands for rat and human α-fetoprotein, Biochim Biophys Acta, 1094, 339, 10.1016/0167-4889(91)90095-F · DOI
  21. Martin, 1996, Interactions between phytoestrogens and human sex steroid binding protein, Life Sci, 58, 429, 10.1016/0024-3205(95)02308-9 · DOI · Paper page
  22. Marrian, 1932, Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares’ urine, Biochem J, 26, 1227, 10.1042/bj0261227 · DOI
  23. Shutt, 1972, Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro, J Endocrinol, 52, 299, 10.1677/joe.0.0520299 · DOI · Paper page
  24. Tang, 1980, Effect of equol on oestrogen receptors and on synthesis of DNA and protein in the immature rat uterus, J Endocrinol, 85, 291, 10.1677/joe.0.0850291 · DOI
  25. Thompson, 1984, Characterization of the estrogenic properties of a nonsteroidal estrogen, equol, extracted from urine of pregnant macaques, Biol Reprod, 31, 705, 10.1095/biolreprod31.4.705 · doi:10.1095/biolreprod31.4.705
  26. Markiewicz, 1993, In vitro bioassays of non-steroidal phytoestrogens, J Steroid Biochem Mol Biol, 45, 399, 10.1016/0960-0760(93)90009-L · DOI · Paper page
  27. Branham, 2002, Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor, J Nutr, 132, 658, 10.1093/jn/132.4.658 · DOI
  28. Kuiper, 1997, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β, Endocrinology, 138, 863, 10.1210/endo.138.3.4979 · DOI · Paper page
  29. Kostelac, 2003, Phytoestrogens modulate binding response of estrogen receptors α and β to the estrogen response element, J Agric Food Chem, 51, 7632, 10.1021/jf034427b · DOI · Paper page
  30. Matsumura, 2005, Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells, J Steroid Biochem Mol Biol, 94, 431, 10.1016/j.jsbmb.2004.12.041 · DOI · Paper page
  31. Carreau, 2009, Respective contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor a induced transcriptional activity by isoflavones and equol: consequence on breast cancer cell proliferation, Mol Nutr Food Res, 53, 652, 10.1002/mnfr.200800061 · DOI
  32. Yee, 2008, Acute and subchronic toxicity and genotoxicity of SE5-OH, an equol-rich product produced by Lactococcus garvieae, Food Chem Toxicol, 46, 2713, 10.1016/j.fct.2008.04.026 · DOI
  33. Messina, 1994, Soy intake and cancer risk: a review of the in vitro and in vivo data, Nutr Cancer, 21, 113, 10.1080/01635589409514310 · DOI · Paper page
  34. Messina, 1997, Phyto-oestrogens and breast cancer, Lancet, 350, 971, 10.1016/S0140-6736(05)64062-7 · DOI
  35. Messina, 2001, Soy for breast cancer survivors: a critical review of the literature, J Nutr, 131, S3095, 10.1093/jn/131.11.3095S · DOI · Paper page
  36. Ju, 2006, Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice, Carcinogenesis, 27, 856, 10.1093/carcin/bgi320 · DOI
  37. Brown, 2010, The chemopreventive action of equol enatiomers in a chemically-induced animal model of breast cancer, Carcinogenesis, 31, 886, 10.1093/carcin/bgq025 · DOI
  38. Ju, 2001, Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice, J Nutr, 131, 2957, 10.1093/jn/131.11.2957 · DOI · Paper page
  39. Imamov, 2004, Estrogen receptor beta in prostate cancer, N Engl J Med, 351, 2773, 10.1056/NEJM200412233512622 · DOI
  40. Akaza, 2004, Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents, Jpn J Clin Oncol, 34, 86, 10.1093/jjco/hyh015 · DOI · Paper page
  41. Ozasa, 2004, Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men, Cancer Sci, 95, 65, 10.1111/j.1349-7006.2004.tb03172.x · DOI · Paper page
  42. Arora, 1998, Antioxidant activities of isoflavones and their biological metabolites in a liposomal system, Arch Biochem Biophys, 356, 133, 10.1006/abbi.1998.0783 · DOI · Paper page
  43. Mitchell, 1998, Antioxidant efficacy of phytoestrogens in chemical and biological model systems, Arch Biochem Biophys, 360, 142, 10.1006/abbi.1998.0951 · DOI · Paper page
  44. Chung, 2008, Antioxidant effects of equol on bovine aortic endothelial cells, Biochem Biophys Res Commun, 375, 420, 10.1016/j.bbrc.2008.08.027 · DOI
  45. Choi, 2009, Evaluation of equol function on anti- or prooxidant status in vivo, J Food Sci, 74, H65, 10.1111/j.1750-3841.2008.01039.x · DOI
  46. Hwang, 2003, The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification, Free Radic Biol Med, 34, 1271, 10.1016/S0891-5849(03)00104-7 · DOI
  47. Salzman, 1999, Isoflavone-mediated inhibition of tyrosine kinase: a novel antiinflammatory approach, J Med Food, 2, 179, 10.1089/jmf.1999.2.179 · doi:10.1089/jmf.1999.2.179
  48. Gimenez, 1997, Renal and vascular actions of equol in the rat, J Hypertens, 15, 1303, 10.1097/00004872-199715110-00015 · DOI
  49. Chin-Dusting, 2001, The vascular activity of some isoflavone metabolites: implications for a cardioprotective role, Br J Pharmacol, 133, 595, 10.1038/sj.bjp.0704088 · DOI
  50. Walker, 2001, The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17β-estradiol, Circulation, 103, 258, 10.1161/01.CIR.103.2.258 · DOI · Paper page
  51. Mahn, 2005, Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo, FASEB J, 19, 1755, 10.1096/fj.05-4008fje · DOI · Paper page
  52. Joy, 2006, The isoflavone equol mediates rapid vascular relaxation: Ca2+-independent activation of endothelial nitric-oxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells, J Biol Chem, 281, 27335, 10.1074/jbc.M602803200 · DOI
  53. Jackman, 2007, Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries, Brain Res, 1141, 99, 10.1016/j.brainres.2007.01.007 · DOI
  54. Cheng, 2010, Soybean isoflavonoid equol blocks ritonavir-Induced endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells, J Nutr, 140, 12, 10.3945/jn.109.110981 · DOI
  55. Chin-Dusting, 2004, The isoflavone metabolite dehydroequol produces vasodilatation in human resistance arteries via a nitric oxide-dependent mechanism, Atherosclerosis, 176, 45, 10.1016/j.atherosclerosis.2004.03.025 · DOI
  56. Teede, 2001, Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women, J Clin Endocrinol Metab, 86, 3053
  57. Steinberg, 2003, Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women, Am J Clin Nutr, 78, 123, 10.1093/ajcn/78.1.123 · DOI · Paper page
  58. Lissin, 2004, Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia, Vasc Med, 9, 26, 10.1191/1358863x04vm531oa · DOI
  59. Petri Nahas, 2004, Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy, Maturitas, 48, 372, 10.1016/j.maturitas.2003.09.026 · DOI
  60. Hermansen, 2005, Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects, Eur J Clin Nutr, 59, 843, 10.1038/sj.ejcn.1602151 · DOI
  61. Colacurci, 2005, Effects of soy isoflavones on endothelial function in healthy postmenopausal women, Menopause, 12, 299, 10.1097/01.GME.0000147017.23173.5B · DOI
  62. Kreijkamp-Kaspers, 2005, Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women, Am J Clin Nutr, 81, 189, 10.1093/ajcn/81.1.189 · DOI
  63. Hall, 2005, Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production, Am J Clin Nutr, 82, 1260, 10.1093/ajcn/82.6.1260 · DOI
  64. Clerici, 2007, Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk, J Nutr, 137, 2270, 10.1093/jn/137.10.2270 · DOI
  65. Tormala, 2008, Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation, Atherosclerosis, 198, 174, 10.1016/j.atherosclerosis.2007.09.010 · DOI
  66. Tormala, 2007, Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation, Climacteric, 10, 471, 10.1080/13697130701624971 · DOI
  67. Ross, 1999, Atherosclerosis: an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207 · DOI · Paper page
  68. Blay, 2010, Isoflavone effect on gene expression profile and biomarkers of inflammation, J Pharm Biomed Anal, 51, 382, 10.1016/j.jpba.2009.03.028 · DOI
  69. Setchell, 2003, Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies, Am J Clin Nutr, 78, S593, 10.1093/ajcn/78.3.593S · DOI · Paper page
  70. Ma, 2008, Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials, Clin Nutr, 27, 57, 10.1016/j.clnu.2007.10.012 · DOI · Paper page
  71. Brink, 2008, Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study, Am J Clin Nutr, 87, 761, 10.1093/ajcn/87.3.761 · DOI
  72. Liu, 2009, Effect of long-term inervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controll trials, Bone, 44, 948, 10.1016/j.bone.2008.12.020 · DOI
  73. Wong, 2009, Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial, Am J Clin Nutr, 90, 1433, 10.3945/ajcn.2009.28001 · DOI
  74. Alekel, 2010, The Soy Isoflavones for Reducing Bone Loss (SIRBL) Study: a 3-y randomized controlled trial in postmenopausal women, Am J Clin Nutr, 91, 218, 10.3945/ajcn.2009.28306 · DOI · Paper page
  75. Marini, 2007, Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial, Ann Intern Med, 146, 839, 10.7326/0003-4819-146-12-200706190-00005 · DOI · Paper page
  76. Wu, 2007, Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial, Menopause, 14, 866, 10.1097/gme.0b013e3180305299 · DOI
  77. Ward, 2005, Serum equol, bone mineral density and biomechanical bone strength differ among four mouse strains, J Nutr Biochem, 16, 743, 10.1016/j.jnutbio.2005.04.002 · DOI
  78. Fujioka, 2004, Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice, J Nutr, 134, 2623, 10.1093/jn/134.10.2623 · DOI
  79. Mathey, 2007, Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol, Osteoporos Int, 18, 671, 10.1007/s00198-007-0351-y · DOI
  80. Rachon, 2007, Effects of dietary equol administration on ovariectomy induced bone loss in Sprague-Dawley rats, Maturitas, 58, 308, 10.1016/j.maturitas.2007.09.005 · DOI
  81. Legette, 2009, Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats, J Nutr, 139, 1908, 10.3945/jn.109.108225 · DOI
  82. Ishiwata, 2009, New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women, Menopause, 16, 141, 10.1097/gme.0b013e31818379fa · DOI
  83. Jou, 2008, Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones, Int J Gynaecol Obstet, 102, 44, 10.1016/j.ijgo.2008.01.028 · DOI
  84. Setchell, 1984, Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease, Am J Clin Nutr, 40, 569, 10.1093/ajcn/40.3.569 · DOI · Paper page

Cited by

See all 211

Metadata

Authors
Setchell, K. D. R., & Clerici, C.
Venue
The Journal of Nutrition
Publisher
Elsevier BV
Published
2010-07
Volume
140
Issue
7
Pages
1363S-1368S
ISSN
0022-3166 (ISSN-L)
OpenAlex
W2003852109
Cited by
211
References
6
FWCI
7.12
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Equol: Pharmacokinetics and Biological Actions ,. https://app.cochat.ai/papers/10.3945/jn.109.119784
The paper
Setchell, K. D. R., & Clerici, C. (2010). Equol: Pharmacokinetics and Biological Actions ,. The Journal of Nutrition. https://doi.org/10.3945/jn.109.119784

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.